Discussion with Dr Carlo Brogna (Italy) and Joachim Gerlach (Germany) regarding this critical research finding, possible causes and potential health implications.
Recap by Tammy AI
1:35: 🔬 Researchers discuss the impact of the circulating Spike protein after vaccination for COVID-19.
7:50: ⚕️ The study on vaccination in Italy had only 20 participants due to difficulty in recruiting doctors and low booster dose rates.
16:06: 🔬 Discussion on potential mechanisms of spike protein integration and production.
21:45: ⚕️ The video discusses the potential link between dysbiosis and long-term symptoms in COVID-19 patients, as well as the impact of MRNA vaccines and antibiotic treatment.
28:01: 🔬 The video discusses the activity of mRNA and the production of Spike protein over a long period of time.
33:52: ⚠️ The spike protein has a high affinity to fuse with cells, posing a warning sign if found free-floating in the blood.
39:37: ⚠️ The video discusses the potential autoimmune response to prolonged exposure to Spike proteins or viral fragments.
45:26: ⚠️ Discussion about the challenges posed by a new variant triggering an autoimmune response and causing micro-clotting.
51:18: ⚕️ Discussion on the importance of mitigating the impact of the ongoing health crisis and the need for people to step outside their ideologies.
Results
The specific PP-Spike fragment was found in 50% of the biological samples analyzed, and its presence was independent of the SARS-CoV-2 IgG antibody titer. The minimum and maximum time at which PP-Spike was detected after vaccination was 69 and 187 days, respectively.
Brogna, Carlo, et al. "Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS‐CoV‐2: Possible molecular mechanisms." PROTEOMICS–Clinical Applications (2023): 2300048.
Excerpt from Transcript
So Carlo, since we know that you have some limited time, I think we want to start off with a very simple question.
Now, you have done research looking at circulating spike protein after vaccination. Now, we were told quite clearly that that kind of thinking was misinformation.
What made you decide to do the research anyway? What was it about it?
Dr Carlo Brogna
Oh, okay. So, first of all, we decided to make this line of research to better understand the half-life period of spike-derived mRNA vaccine.
So we are curious to know if, first of all, the mRNA and spike protein will stay in the muscle. Yeah, okay, in the lymph node here or go in the circulation?
First of all, this is the first question of our paper.
The second question is to understand for how many times the spike protein derived from mRNA vaccine will stay in the circulation and to better understand the limit in which sense someone could ask.
The limit to understand if this spike vaccine, spike protein grow up the antibodies and if these antibodies protect or help the person to don't have infection of SARS-CoV-2. And we have discovered that everyone of us have understand that the title of antibodies is not sure to not the don't have the infection of SARS-CoV-2 and many person that have a total antibodies height at the same time go infected by SARS-CoV-2
And we also wanted to understand how, I just said before, the real half time of the spike protein, because if the spike protein stays for many times, one month, two months, three months, four months, six months, before the booster dose,
It is important to know because if I have a spike protein and I have antibody level high or low, sometimes maybe the spike protein is read from our body as a self and non-self protein. So this is a very important.
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.
Implications of Ongoing Circulating Vaccine Spike Protein